Search - tctmd.com

Displaying 41 - 60 of 4235

Sort: Relevancy | Date

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Nonatherosclerotic Causes of MI Common in Younger Patients

L.A. McKeown

September 17, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Conference News ESC 2025

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Caitlin E. Cox

September 08, 2025

News Conference News ESC 2025

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

Caitlin E. Cox

September 05, 2025

Presentation ESC 2025

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Presenter: David Newby

September 03, 2025

News Conference News ESC 2025

HELP-MI SWEDEHEART: Routine H. Pylori Screening Doesn’t Lessen Bleeding After MI

Todd Neale

September 03, 2025

News Conference News ESC 2025

ICD No Help for High-Risk, Post-MI Patients With Moderately Reduced EF

Todd Neale

September 02, 2025

Presentation ESC 2025

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Presenter: Anders Jeppsson

September 01, 2025

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

Presentation ESC 2025

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Presenter: Robin Hofmann

August 31, 2025

News Conference News ESC 2025

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

Caitlin E. Cox

August 31, 2025

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

Presentation ESC 2025

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Presenter: Pedro A. Lemos

August 30, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

Presentation TCT India 2025

How do we predict risk in complex/high-risk PCI? Using scores and paradigms effectively

Presenter: Sundeep Mishra

July 27, 2025

Presentation TCT India 2025

How do we systematically analyse complications and improve practice? A step-by-step example of learning implementation

Presenter: Sanjog Kalra

July 27, 2025

Advertisement

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Nonatherosclerotic Causes of MI Common in Younger Patients

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

HELP-MI SWEDEHEART: Routine H. Pylori Screening Doesn’t Lessen Bleeding After MI

ICD No Help for High-Risk, Post-MI Patients With Moderately Reduced EF

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

How do we predict risk in complex/high-risk PCI? Using scores and paradigms effectively

How do we systematically analyse complications and improve practice? A step-by-step example of learning implementation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content